nach oben

Journal of Genetic Counseling

Erschienen in:

24.12.2016 | Case Presentation

The Confluence of Psychiatric Symptoms and Neurodegenerative Disease: Impact on Genetic Counseling

verfasst von: Jill S. Goldman, Edward D. Huey, Deborah Z. Thorne

Erschienen in: Journal of Genetic Counseling | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Hereditary neurodegenerative diseases can present with a psychiatric prodrome that overlaps with psychiatric symptoms that are not primary to these diseases. When individuals present for predictive testing while experiencing such symptoms, clinicians including genetic counselors, must proceed with caution and evaluate each situation on a case-by-case basis. Legitimate reasons may exist for moving forward with testing. Additionally predicting the consequences of testing is unrealistic so that the clinicians must do their best to prepare patients for both positive and negative results. A multidisciplinary team following the Huntington disease protocol remains the gold standard care for predictive testing for such patients. We discuss 3 case histories that demonstrate the complex nature of genetic counseling and testing in the presence of psychiatric symptoms, whether emanating from the disease itself or the results of living in an affected family.

Almqvist, E. W., Brinkman, R. R., Wiggins, S., & Hayden, M. R. (2003). Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington’s disease. Clinical Genetics, 64, 300–309.CrossRefPubMed

Arighi, A., Fumagalli, G. G., Jacini, F., Fenoglio, C., Ghezzi, C., Pietroboni, A. M., De Riz, M., et al. (2012). Early onset behavioral variant frontotemporal dementia due to C9ORF72 hexanucleotide repeat expansion: psychiatric clinical presentations. Journal of Alzheimer's Disease, 31, 447–452.PubMed

Bang, J., Spina, S., & Miller, B. L. (2015). Frontotemporal dementia. Lancet, 386, 1672–1682.CrossRefPubMed

Block, N. R., Sha, S. J., Karydas, A. M., Fong, J. C., De May, M. G., Miller, B. L., & Rosen, H. J. (2016). Frontotemporal dementia and psychiatric illness: emerging clinical and biological links in gene carriers. American Journal of Geriatric Psychiatry, 24, 107–116.CrossRefPubMed

Broadstock, M., Michie, S., & Marteau, T. (2000). Psychological consequences of predictive genetic testing: a systematic review. European Journal of Human Genetics, 8, 731–738.CrossRefPubMed

Calvo, A., Moglia, C., Canosa, A., Cistaro, A., Valentini, C., Carrara, G., Soldano, E., et al. (2012). Amyotrophic lateral sclerosis/frontotemporal dementia with predominant manifestations of obsessive-compulsive disorder associated to GGGGCC expansion of the c9orf72 gene. Journal of Neurology, 259, 2723–2725.CrossRefPubMed

Dale, M., Maltby, J., Shimozaki, S., Cramp, R., Rickards, H., & REGISTRY Investigators of the European Huntington’s Disease Network (2016). Disease stage, but not sex, predicts depression and psychological distress in Huntington’s disease: a European population study. Journal of Psychosomatic Research, 80, 17–22.CrossRefPubMed

Decruyenaere, M., Evers-Kiebooms, G., Boogaerts, A., Cassiman, J. J., Cloostermans, T., Demyttenaere, K., Dom, R., Fryns, J. P., & Van den Berghe, H. (1996). Prediction of psychological functioning one year after the predictive test for Huntington’s disease and impact of the test result on reproductive decision making. Journal of Medical Genetics, 33(9), 737–743.CrossRefPubMedPubMedCentral

Decruyenaere, M., Evers-Kiebooms, G., Cloostermans, T., Boogaerts, A., Demyttenaere, K., Dom, R., & Fryns, J. P. (2003). Psychological distress in the 5-year period after predictive testing for Huntington’s disease. European Journal of Human Genetics, 2003(11), 30–38.CrossRef

Ducharme, S., Price, B. H., Larvie, M., Dougherty, D. D., & Dickerson, B. C. (2015). Clinical approach to the differential diagnosis between behavioral variant frontotemporal dementia and primary psychiatric disorders. American Journal of Psychiatry, 172, 827–837.CrossRefPubMed

Duff, K., Paulsen, J. S., Beglinger, L. J., Langbehn, D. R., Wang, C., Stout, J. C., Ross, C. A., Predict-HD Investigators of the Huntington Study Group, et al. (2010). “Frontal” behaviors before the diagnosis of Huntington’s disease and their relationship to markers of disease progression: evidence of early lack of awareness. Journal of Neuropsychiatry and Clinical Neurosciences, 22, 196–207.CrossRefPubMedPubMedCentral

Duisterhof, M., Trijsburg, R. W., Niermeijer, M. F., Roos, R. A., & Tibben, A. (2001). Psychological studies in Huntington’s disease: making up the balance. Journal of Medical Genetics, 38, 852–856.CrossRefPubMedPubMedCentral

Epping, E. A., Mills, J. A., Beglinger, L. J., Fiedorowicz, J. G., Craufurd, D., Smith, M. M., Groves, M., PREDICT-HD Investigators and Coordinators of the Huntington Study Group, et al. (2013). Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study. Journal of Psychiatric Research, 47, 1423–1431.CrossRefPubMed

Epping, E. A., Kim, J. I., Craufurd, D., Brashers-Krug, T. M., Anderson, K. E., McCusker, E., Luther, J., Long, J. D., Paulsen, J. S., & PREDICT-HD Investigators and Coordinators of the Huntington Study Group (2016). Longitudinal psychiatric symptoms in prodromal Huntington’s disease: a decade of data. American Journal of Psychiatry, 173, 184–192.CrossRefPubMed

Evers-Kiebooms, G., & Decruyenaere, M. (1998). Predictive testing for Huntington’s disease: a challenge for persons at risk and for professionals. Patient Education and Counseling, 35, 15–26.CrossRefPubMed

Floris, G., Borghero, G., Cannas, A., Di Stefano, F., Costantino, E., Murru, M. R., Brunetti, M., et al. (2012). Frontotemporal dementia with psychosis, parkinsonism, visuo-spatial dysfunction, upper motor neuron involvement associated to expansion of C9ORF72: a peculiar phenotype? Journal of Neurology, 259, 1749–1751.CrossRefPubMedPubMedCentral

Galimberti, D., Fenoglio, C., Serpente, M., Villa, C., Bonsi, R., Arighi, A., Fumagalli, G. G., et al. (2013). Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation. Biological Psychiatry, 74, 384–391.CrossRefPubMed

Galimberti, D., Reif, A., Dell’Orso, B., Palazzo, C., Villa, C., Fenoglio, C., Kittel-Schneider, S., et al. (2014a). C9ORF72 hexanucleotide repeat expansion as a rare cause of bipolar disorder. Bipolar Disorders, 16, 448–449.CrossRefPubMed

Galimberti, D., Reif, A., Dell’Orso, B., Kittel-Schneider, S., Leonard, C., Herr, A., Palazzo, C., et al. (2014b). The C9ORF72 hexanucleotide repeat expansion is a rare cause of schizophrenia. Neurobiology of Aging, 35, 1214.CrossRefPubMed

Galimberti, D., Dell’Osso, B., Altamura, A. C., & Scarpini, E. (2015). Psychiatric symptoms in frontotemporal dementia: epidemiology, phenotypes, and differential diagnosis. Biological Psychiatry, 78, 684–692.CrossRefPubMed

Hallam, B.J., Silverberg, N.D., Lamarre, A.K., Mackenzie, I.R., Feldman, H.H. (2007–2008). Clinical presentation of prodromal frontotemporal dementia. American Journal of Alzheimer’s Disease and Other Dementias, 22, 456–467.

Huey, E. D., Nagy, P. L., Rodriguez-Murillo, L., Manoochehri, M., Goldman, J., Lieberman, J., Karayiorgou, M., & Mayeux, R. (2013). C9ORF72 repeat expansions not detected in a group of patients with schizophrenia. Neurobiology of Aging, 34, 1309.CrossRefPubMed

International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington’s Chorea (1994). Guidelines for the molecular genetics predictive test in Huntington’s disease. Neurology, 44, 1533–1536.CrossRef

Julien, C. L., Thompson, J. C., Wild, S., Yardumian, P., Snowden, J. S., Turner, G., & Craufurd, D. (2007). Psychiatric disorders in preclinical Huntington’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 78, 939–943.CrossRefPubMed

Kertesz, A., Ang, L. C., Jesso, S., MacKinley, J., Baker, M., Brown, P., Shoesmith, C., et al. (2013). Psychosis and hallucinations in frontotemporal dementia with the C9ORF72 mutation: a detailed clinical cohort. Cognitive and Behavioral Neurology, 26, 146–154.CrossRefPubMedPubMedCentral

Klitzman, R. (2009). “Am I my genes?”: questions of identity among individuals confronting genetic disease. Genetics in Medicine, 11, 880–889.CrossRefPubMedPubMedCentral

Lanata, S. C., & Miller, B. L. (2016). The behavioural variant frontotemporal dementia (bvFTD) syndrome in psychiatry. Journal of Neurology, Neurosurgery and Psychiatry, 87, 501–511.CrossRefPubMed

MacLeod, R., Tibben, A., Frontali, M., Evers-Kiebooms, G., Jones, A., Martinez-Descales, A., Roos, R. A., & Editorial Committee and Working Group ‘Genetic Testing Counselling’ of the European Huntington Disease Network (2013). Recommendations for the predictive genetic test in Huntington’s disease. Clinical Genetics, 83, 221–231.CrossRefPubMed

Mand, C. M., Gillam, L., Duncan, R. E., & Delatycki, M. B. (2015). “I’m scared of being like mum”: the experience of adolescents living in families with Huntington disease. Journal of Huntington’s Disease, 4, 209–217.CrossRefPubMed

Marshall, J., White, K., Weaver, M., Wetherill, L. F., Hui, S., Stout, J. C., Johnson, S. A., et al. (2007). Specific psychiatric manifestations among preclinical Huntington disease mutation carriers. Archives of Neurology, 64, 116–121.CrossRefPubMed

Meisler, M. H., Grant, A. E., Jones, J. M., Lenk, G. M., He, F., Todd, P. K., Kamali, M., et al. (2013). C9ORF72 expansion in a family with bipolar disorder. Bipolar Disorders, 15, 326–332.CrossRefPubMedPubMedCentral

Paulsen, J. S. (2010). Early detection of Huntington’s disease. Future Neurology, 5, 85–104.CrossRef

Paulsen, J. S., Langbehn, D. R., Stout, J. C., Aylward, E., Ross, C. A., Nance, M., Guttman, M., Predict-HD Investigators and Coordinators of the Huntington Study Group, et al. (2008). Detection of Huntington’s disease decades before diagnosis: the Predict-HD study. Journal of Neurology, Neurosurgery and Psychiatry, 79, 874–880.CrossRefPubMed

Paulsen, J. S., Nance, M., Kim, J. I., Carlozzi, N. E., Panegyres, P. K., Erwin, C., Goh, A., et al. (2013). A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases. Progress in Neurobiology, 110, 2–28.CrossRefPubMed

Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., et al. (2011). Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain, 134, 2456–2477.CrossRefPubMedPubMedCentral

Reilmann, R., Leavitt, B. R., & Ross, C. A. (2014). Diagnostic criteria for Huntington’s disease based on natural history. Movement Disorders, 29, 1335–1341.CrossRefPubMed

Robins Wahlin, T. B. (2007). To know or not to know: a review of behaviour and suicidal ideation in preclinical Huntington’s disease. Patient Education Counseling, 65, 279–287.CrossRefPubMed

Ross, C. A., Aylward, E. H., Wild, E. J., Langbehn, D. R., Long, J. D., Warner, J. H., Scahill, R. I., et al. (2014). Huntington disease: natural history, biomarkers and prospects for therapeutics. Nature Reviews Neurology, 10, 204–216.CrossRefPubMed

Snowden, J. S., Rollinson, S., Thompson, J. C., Harris, J. M., Stopford, C. L., Richardson, A. M., Jones, M., et al. (2012). Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain, 135, 693–708.CrossRefPubMedPubMedCentral

Tabrizi, S. J., Scahill, R. I., Owen, G., Durr, A., Leavitt, B. R., Roos, R. A., Borowsky, B., et al. (2013). Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington’s disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurology, 12, 637–649.CrossRefPubMed

Timman, R., Roos, R., Maat-Kievit, A., & Tibben, A. (2004). Adverse effects of predictive testing for Huntington disease underestimated: long-term effects 7–10 years after the test. Health Psychology, 23, 189–197.CrossRefPubMed

van der Meer, L. B., van Duijn, E., Wolterbeek, R., & Tibben, A. (2012). Adverse childhood experiences of persons at risk for Huntington’s disease or BRCA1/2 hereditary breast/ovarian cancer. Clinical Genetics, 81, 18–23.CrossRefPubMed

van der Meer, L. B., van Duijn, E., Giltay, E. J., & Tibben, A. (2015). Do attachment style and emotion regulation strategies indicate distress in predictive testing? Journal of Genetic Counseling, 24, 862–871.CrossRefPubMedPubMedCentral

Watson, A., Pribadi, M., Chowdari, K., Clifton, S., Wood, J., Miller, B. L., Coppola, G., & Nimgaonkar, V. (2016). C9orf72 repeat expansions that cause frontotemporal dementia are detectable among patients with psychosis. Psychiatry Research, 235, 200–202.CrossRefPubMed

Woolley, J. D., Khan, B. K., Murthy, N. K., Miller, B. L., & Rankin, K. P. (2011). The diagnostic.challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. Journal of Clinical Psychiatry, 72, 126–133.CrossRefPubMedPubMedCentral

Wylie, M. A., Shnall, A., Onyike, C. U., & Huey, E. D. (2013). Management of Frontotemporal dementia in mental health and multidisciplinary settings. International Review of Psychiatry, 25, 230–236.CrossRefPubMedPubMedCentral

Zanardini, R., Ciani, M., Benussi, L., & Ghidoni, R. (2016). Molecular pathways bridging frontotemporal lobar degeneration and psychiatric disorders. Frontiers in Aging Neuroscience, 8, 10.CrossRefPubMedPubMedCentral

Titel: The Confluence of Psychiatric Symptoms and Neurodegenerative Disease: Impact on Genetic Counseling
verfasst von: Jill S. Goldman
Edward D. Huey
Deborah Z. Thorne
Publikationsdatum: 24.12.2016
Verlag: Springer US
Erschienen in: Journal of Genetic Counseling / Ausgabe 3/2017
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI: https://doi.org/10.1007/s10897-016-0056-5

Neu im Fachgebiet Gynäkologie und Geburtshilfe

16.04.2024 | Maligne primäre ZNS-Tumoren | Nachrichten

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

The Confluence of Psychiatric Symptoms and Neurodegenerative Disease: Impact on Genetic Counseling

Abstract

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Manche Gestagene können das Risiko für Meningeome erhöhen

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Chronische Schmerzen nach Op. oft mit neuropathischer Komponente

Das Ende der vollständigen axillären Lymphknotendissektion

Update Gynäkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2017

Parents’ Understanding of Genetics and Heritability

“I Don’t Want to Be an Ostrich”: Managing Mothers’ Uncertainty during BRCA1/2 Genetic Counseling

A Rapid Systematic Review of Outcomes Studies in Genetic Counseling

Patients with Amyotrophic Lateral Sclerosis Have High Interest in and Limited Access to Genetic Testing

Is Symptomatic Long QT Syndrome Associated with Depression in Women and Men?

Clinical Cancer Genetics Disparities among Latinos

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Manche Gestagene können das Risiko für Meningeome erhöhen

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Chronische Schmerzen nach Op. oft mit neuropathischer Komponente

Das Ende der vollständigen axillären Lymphknotendissektion

Update Gynäkologie